Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty
about
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@ast
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@en
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@nl
type
label
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@ast
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@en
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@nl
prefLabel
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@ast
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@en
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@nl
P2093
P2860
P356
P1433
P1476
Pharmacodynamics and safety of ...... ndergoing elective angioplasty
@en
P2093
C van Der Zwaan
H Suryapranata
J Hoffmann
J W Deckers
K M Akkerhuis
L R van Der Wieken
M J van Den Brand
M L Simoons
P2860
P304
P356
10.1136/HEART.85.4.444
P407
P577
2001-04-01T00:00:00Z